Provided by Tiger Trade Technology Pte. Ltd.

SITC

27.640
+0.4801.77%
Volume:5.09M
Turnover:139.30M
Market Cap:74.63B
PE:9.12
High:27.640
Open:27.340
Low:26.780
Close:27.160
52wk High:32.179
52wk Low:13.698
Shares:2.70B
HK Float Shares:2.70B
Volume Ratio:0.86
T/O Rate:0.19%
Dividend:2.75
Dividend Rate:9.93%
EPS(LYR):3.030
ROE:55.92%
ROA:25.43%
PB:3.73
PE(LYR):9.12
PS:2.80

Loading ...

Shipping Stocks Rally in Afternoon Trading as U.S.-China Trade Talks Yield Consensus; Institutions Expect Rapid Recovery in Maritime Trade

Stock News
·
Nov 03, 2025

Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025

GlobeNewswire
·
Nov 03, 2025

Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting

GlobeNewswire
·
Oct 30, 2025

ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting

GlobeNewswire
·
Oct 30, 2025

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

GlobeNewswire
·
Oct 30, 2025

New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
Oct 30, 2025

CICC Maintains Outperform Rating on SITC (01308) with Target Price of HK$36

Stock News
·
Oct 28, 2025

SITC International's Nine-month Revenue Jumps 17%

MT Newswires Live
·
Oct 24, 2025

SITC Reports Revenue of Approximately $2.459 Billion for the First Three Quarters, Up Approximately 16.6% Year-on-Year

Stock News
·
Oct 24, 2025

SITC International Holdings (1308) Reports 16.6% Revenue Growth and Updates on Share Scheme

Bulletin Express
·
Oct 24, 2025

SITC International Holdings 9-Month Revenue USD 2,108.5 Million

THOMSON REUTERS
·
Oct 24, 2025

IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting

GlobeNewswire
·
Oct 23, 2025

SITC International Opens New Logistics Office in Wuxi

Reuters
·
Oct 22, 2025

SITC Line Korea Highlights ESG Practices in 2025 Team-Building Event

Reuters
·
Oct 21, 2025

SITC International Holdings Company Limited's (HKG:1308) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.
·
Oct 19, 2025

Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
Oct 08, 2025

Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025

GlobeNewswire
·
Oct 06, 2025

Akari Therapeutics Announces Abstract Accepted for Oral Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting

GlobeNewswire
·
Oct 03, 2025

Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire
·
Oct 03, 2025

ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
Oct 03, 2025